NCT04592614: CTM-NS

Choose to Move - Next Steps: Can 'Booster Sessions' Sustain Health Benefits of an Effective, Scaled-up, Health Promotion Program?

Completed NA Last updated 27 March 2025

What this trial tests

NA trial testing Choose to Move - Next Steps in Aging in 424 participants. Completed in 29 January 2025.

Timeline

7 January 2020

Primary endpoint
29 January 2025

29 January 2025

Quick facts

Lead sponsor	University of British Columbia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	424
Start date	7 January 2020
Primary completion	29 January 2025
Estimated completion	29 January 2025
Sites	1 location across Canada

Drugs / interventions tested

• Choose to Move - Next Steps

Conditions studied

• Aging — all drugs for Aging →
• Mobility Limitation — all drugs for Mobility Limitation →
• Sedentary Behavior — all drugs for Sedentary Behavior →
• Loneliness — all drugs for Loneliness →

Sponsor

University of British Columbia

Who can join

60 and older, any sex, with Aging or Mobility Limitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One-third of Canadians will be older adults (\>65y) by 2050. Thus, healthy aging is a public health priority. Many older adult health promoting interventions have been implemented, yet few were scaled-up and sustained. Choose to Move (CTM) is an effective, adaptable, community-based health promotion program for older adults. CTM, co-created with government and community stakeholders, has been scaled-up across British Columbia (BC) using a phased approach (2015-2021). The investigators evaluated the impact of CTM on the health of seniors who participated and the results were extremely positive: CTM increased mobility, physical activity, social connectedness and improved mental health indicators like loneliness. When these outcomes were assessed again, one year after the end of CTM, these improvements had diminished.

In this trial the investigators aim to determine if health benefits of CTM can be maintained by providing ongoing support to CTM participants. Booster interventions have been defined as "brief contacts beyond the main part of the intervention to reinforce previous intervention content" (Fjeldsoe et al., 2011, p. 601). Choose to Move - Next Steps (CTM-NS) is a two-year intervention where participants who recently completed CTM will receive different doses of a 'booster' program. Specifically, participants will be randomly allocated to virtual group meetings on a monthly (study arm 1; high dose) or quarterly (study arm 2; low dose) basis. Group meetings will be facilitated by an Activity Coach.

Objectives:

The investigators will conduct 1) impact, 2) implementation, and 3) economic evaluations of CTM-NS across 24 months.

Hypotheses:

For objective 1, the investigators hypothesize that improvements in older adult participant outcomes (primary outcome: mobility; secondary outcomes: physical activity, loneliness, social isolation, social connectedness, sitting time, screen time, social network, health status) obtained during CTM will be maintained over the 2 year CTM-NS study. Participants in the monthly group meetings (study arm 1) will maintain benefits to a greater degree than participants in the quarterly group meetings (study arm 2). Objectives 2 and 3 are descriptive and therefore have no hypotheses.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. What is the 'voltage drop' when an effective health promoting intervention for older adults-Choose to Move (Phase 3)-Is implemented at broad scale?
   McKay HA, Macdonald HM, Nettlefold L, Weatherson K, et al · · 2023 · cited 10× · PMID 37146002 · DOI 10.1371/journal.pone.0268164